GB Patent

GB0400804D0 — Pharmaceutical compositions

Assigned to MERKUS, FRANCISCUS W H · Expires 2004-02-18 · 22y expired

What this patent protects

Compositions of midazolam, a benzodiazapine, in concentrations of 35-100 mg/ml are disclosed for the treatment of anxiety, epilepsy and epileptic seizures, invasive surgical procedures and diagnostic procedures and sedation. These compositions are particularly characterized by a …

USPTO Abstract

Compositions of midazolam, a benzodiazapine, in concentrations of 35-100 mg/ml are disclosed for the treatment of anxiety, epilepsy and epileptic seizures, invasive surgical procedures and diagnostic procedures and sedation. These compositions are particularly characterized by a solubilizer such an propylene glycol. Preferably, the compositions are aqueous solutions for intranasal administration.

Drugs covered by this patent

Patent Metadata

Patent number
GB0400804D0
Jurisdiction
GB
Classification
—
Expires
2004-02-18
Drug substance claim
No
Drug product claim
No
Assignee
MERKUS, FRANCISCUS W H
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.